UJL
1-[(7~{S})-5,7-dihydro-4~{H}-thieno[2,3-c]pyran-7-yl]-~{N}-methyl-methanamine
Find entries where: UJL
is present as a standalone ligand in 6 entries
Chemical Component Summary | |
---|---|
Name | 1-[(7~{S})-5,7-dihydro-4~{H}-thieno[2,3-c]pyran-7-yl]-~{N}-methyl-methanamine |
Synonyms | Ulotaront; SEP-363856; SEP-856 |
Identifiers | 1-[(7~{S})-5,7-dihydro-4~{H}-thieno[2,3-c]pyran-7-yl]-~{N}-methyl-methanamine |
Formula | C9 H13 N O S |
Molecular Weight | 183.271 |
Type | NON-POLYMER |
Isomeric SMILES | CNC[C@H]1c2c(ccs2)CCO1 |
InChI | InChI=1S/C9H13NOS/c1-10-6-8-9-7(2-4-11-8)3-5-12-9/h3,5,8,10H,2,4,6H2,1H3/t8-/m0/s1 |
InChIKey | ABDDQTDRAHXHOC-QMMMGPOBSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 25 |
Chiral Atom Count | 1 |
Bond Count | 26 |
Aromatic Bond Count | 5 |
Drug Info: DrugBank
DrugBank ID | DB15665 |
---|---|
Name | SEP-363856 |
Groups | investigational |
Description | SEP-363856 is a novel psychotropic drug being investigated for the treatment of schizophrenia. Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT1A).[A193506] SEP-363856 was developed by Sunovion pharmaceuticals.[L12891] An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia. Negative symptoms of schizophrenia are more difficult to treat and may include flattened affect, anhedonia, and social withdrawal. Additional clinical trials of SEP-363856 are required to confirm the safety and efficacy of this drug.[A193506] |
Synonyms | SEP-363856 |
CAS number | 1310426-33-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Trace amine-associated receptor 1 | MMPFCHNIINISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISH... | unknown | agonist |
5-hydroxytryptamine receptor 1A | MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA... | unknown | agonist |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 89532783 |
ChEMBL | CHEMBL4650337 |